Dosing regimen of gentamicin in neonates: evaluation of current guidelines based on a large population pharmacokinetic analysis by Fuchs, A. et al.
Abstract P980
 
Dosing regimen of gentamicin in neonates: 
evaluation of current guidelines based on 
a large population pharmacokinetic 
analysis
 
 
A. Fuchs1, M. Guidi1,2, E. Giannoni3, D. Werner4, N. Widmer1, T. Buclin1, C. Csajka1,2
1Division of Clinical Pharmacology, Service of Biomedicine, Department of Laboratory, Centre Hospitalier Universitaire Vaudois and University of 
Lausanne, Lausanne, 2School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, 3Service of Neonatology, 
Department of Pediatrics, 4Clinical Chemistry Laboratory, Service of Biomedicine, Centre Hospitalier Universitaire Vaudois and University of 
Lausanne, Lausanne, Switzerland
 
Objectives: Gentamicin is among the most commonly prescribed antibiotics in newborns, but large interindividual variability in exposure levels 
exists. Based on a population pharmacokinetic analysis of a cohort of unselected neonates, we aimed to validate current dosing recommendations 
from a recent reference guideline (Neofax® ).  
Methods: From 3039 concentrations collected in 994 preterm (median gestational age 32.3 weeks, range 24.2-36.5) and 455 term newborns, 
treated at the University Hospital of Lausanne between 2006 and 2011, a population pharmacokinetic analysis was performed with NONMEM®. 
Model-based simulations were used to assess the ability of dosing regimens to bring concentrations into targets: trough ≤ 1mg/L and peak ~ 
8mg/L.  
Results: A two-compartment model best characterized gentamicin pharmacokinetics. Model parameters are presented in the table 
[Parameters estimates of final model]
. Body weight, gestational age and postnatal age positively influence clearance, which decreases under dopamine administration. Body weight and 
gestational age influence the distribution volume. Model based simulations confirm that preterm infants need doses superior to 4 mg/kg, and 
extended dosage intervals, up to 48 hours for very preterm newborns, whereas most term newborns would achieve adequate exposure under 4 
mg/kg q. 24 h. More than 90% of neonates would achieve trough concentrations below 2 mg/L and peaks above 6 mg/L following most recent 
guidelines.  
Conclusions: Simulated gentamicin exposure demonstrates good accordance with recent dosing recommendations for target concentration 
achievement.
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